FDA Amends Final Monograph for Over-the-Counter Astringent Skin Products

Summary

The Food and Drug Administration (FDA) has issued a technical amendment to its final monograph for over-the-counter (OTC) skin protectant astringent drug products, clarifying that certain aluminum-based solutions are generally recognized as safe and effective, and outlining how manufacturers should relabel these products to comply with the monograph.